Friday, March 31, 2023
Clinical Advances in
Patients with dementia and symptoms of psychosis are at risk for poor quality of life and early institutionalization. Limited current clinical guidance and evidence on the clinical efficacy of commonly used antipsychotics can make it a challenge for clinicians to diagnose and treat these patients. This collection provides vital information on the pathophysiology of dementia-related psychosis (DRP), strategies for diagnosing and managing patients with DRP, and the latest data on available and investigational therapies.
Supported by an independent educational grant from
ACADIA Pharmaceuticals Inc.
Download the expert summary on the diagnosis and etiopathology of Dementia-related-psychosis
Download
Steering Committee Chair
Research Professor of Psychiatry
University of Arizona College of Medicine
Director Banner Alzheimer's Institute
Phoenix, Arizona
Professor of Psychiatry and Neurology
Columbia University
New York, New York
Samuel W. Fordyce Professor
Director, Geriatric Psychiatry
St Louis University School of Medicine
St Louis, Missouri
Clinical Professor of Psychiatry
University of California, San Diego
La Jolla, California
Friends of Alzheimer's Research Endowed Professor of Psychiatry
Washington University School of Medicine
St. Louis, Missouri
Professor of Psychiatry & Biobehavioral Sciences
Parlow Solomon Professor on Aging
Director, UCLA Longevity Center
University of California, Los Angeles
Steering Committee Chair
Has disclosed the following relevant financial relationships
Served as an advisor or consultant for: AbbVie Inc.; AC Immune SA; ACADIA Pharmaceuticals Inc.; AstraZeneca Pharmaceuticals LP; Auspex Pharmaceuticals, Inc.; Avanir Pharmaceuticals; Biogen; Boehringer Ingelheim Pharmaceuticals, Inc.; Brain Test Inc; Chase Pharmaceuticals Corporation; Cognoptix, Inc.; Corium International, Inc.; Eisai Inc.; GliaCure Inc.; INSYS Therapeutics, Inc.; Lilly; H. Lundbeck A/S; Merck & Co., Inc.; Pfizer Inc.; Roche; T3D Therapeutics
Received grants for clinical research from: Amgen Inc.; AstraZeneca Pharmaceuticals LP; Avanir Pharmaceuticals; Avid Radiopharmaceuticals; Biogen; Brain Test Inc; Cognoptix, Inc.; Functional Neuromodulation, Ltd.; GE Healthcare; Genentech, Inc.; Lilly; H. Lundbeck A/S; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Roche; Takeda Pharmaceuticals North America, Inc.; Targacept, Inc.
Owns stock, stock options, or bonds from: Adamas Pharmaceuticals, Inc.
Has disclosed the following relevant financial relationships
Served as an advisor or consultant for: ACADIA Pharmaceuticals Inc.; Avanir Pharmaceuticals; Eisai Inc.; Genentech, Inc.; Neuronix
Has disclosed the following relevant financial relationships
Served as an advisor or consultant for: ACADIA Pharmaceuticals Inc.; Alkahest, Inc.; Allergan, Inc.; Avanir Pharmaceuticals; Axovant Sciences; BioXcel Therapeutics; GE Healthcare; Genentech, Inc.; Lundbeck, Inc.; Novartis Pharmaceuticals Corporation; Otsuka Pharmaceutical Co., Ltd.; Roche; Takeda Pharmaceuticals North America, Inc.
Served as a speaker or a member of a speakers bureau for: ACADIA Pharmaceuticals Inc.
Other: Safety Monitoring Committee: EryDel SPA - P.I.; Merck & Co., Inc.; Newron Pharmaceuticals SPA
Has disclosed the following relevant financial relationships
Served as an advisor or consultant for: ACADIA Pharmaceuticals Inc.; Alkermes, Inc; Allergan, Inc.; Intra-Cellular Therapies, Inc.; Neurocrine Biosciences, Inc.; Teva Pharmaceuticals USA
Served as a speaker or a member of a speakers bureau for: ACADIA Pharmaceuticals Inc.; Alkermes, Inc; Allergan, Inc.; Merck & Co., Inc.; Neurocrine Biosciences, Inc.; Otsuka Pharmaceutical Co., Ltd.; Sunovion Pharmaceuticals Inc.; Teva Pharmaceuticals USA
Has disclosed the following relevant financial relationships
Served as an advisor or consultant for: ACADIA Pharmaceuticals Inc.; Avanir Pharmaceuticals
Owns stock, stock options, or bonds from: Bristol-Myers Squibb Company; Elan Pharmaceuticals
Has disclosed the following relevant financial relationships
Served as an advisor or consultant for: ACADIA Pharmaceuticals Inc.; Allergan, Inc.; Avanir Pharmaceuticals; Genentech, Inc.; Hemlock; Herbalife; Roche; Theravalues
Served as a speaker or a member of a speakers bureau for: ACADIA Pharmaceuticals Inc.; Allergan, Inc.; Avanir Pharmaceuticals; Genentech, Inc.; Hemlock; Herbalife; Roche; Theravalues
Owns stock, stock options, or bonds from: Caremark LLC